<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">477113869</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180405111617.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170330e19960101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF00451976</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF00451976</subfield>
  </datafield>
  <datafield tag="100" ind1="1" ind2=" ">
   <subfield code="a">Ogilvie</subfield>
   <subfield code="D">Richard</subfield>
   <subfield code="u">Hypertension Unit, Clinical Pharmacology, The Toronto Hospital Western Division, Professor of Medicine &amp; Pharmacology, University of Toronto, 399 Bathurst Street, M5T 2S8, Toronto, Ontario</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="245" ind1="1" ind2="0">
   <subfield code="a">Hypertension in the elderly: Therapeutic recommendations developed from controlled trials</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Richard Ogilvie]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Several clincal trials of anti-hypertensive treatment of the older patient have demonstrated significant reductions in cardiovascular morbidity and mortality as well as hospitalisation. Therapeutic recommendations have been developed from the results of these trials. The threshold for treatment comes from the recognition of benefit being related to absolute risk for patients with isolated systolic pressure &gt; 160 mm Hg or combined systolic/diastolic hypertension with a pressure &gt; 160/100 mm Hg. The treatment goal is a normal pressure &lt; 140/90 mm Hg without adverse effects. Low-dose diuretic therapy is recommended as initial treatment along with non-drug measures.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Kluwer Academic Publishers, 1996</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Hypertension</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">hypertensive therapy</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">diuretics</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">beta blockers</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">calcium blockers</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">hypertensive and cardiac mortality</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">systolic hypertension</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Geriatric Nephrology and Urology</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">6/1(1996-01-01), 43-47</subfield>
   <subfield code="x">0924-8455</subfield>
   <subfield code="q">6:1&lt;43</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">6</subfield>
   <subfield code="o">10715</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF00451976</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">review-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF00451976</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">100</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ogilvie</subfield>
   <subfield code="D">Richard</subfield>
   <subfield code="u">Hypertension Unit, Clinical Pharmacology, The Toronto Hospital Western Division, Professor of Medicine &amp; Pharmacology, University of Toronto, 399 Bathurst Street, M5T 2S8, Toronto, Ontario</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Geriatric Nephrology and Urology</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">6/1(1996-01-01), 43-47</subfield>
   <subfield code="x">0924-8455</subfield>
   <subfield code="q">6:1&lt;43</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">6</subfield>
   <subfield code="o">10715</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
